80 Infos zu Per-ola Freskgård

1 Aktuelle Nachrichten

1 Profile in Sozialen Netzwerken

Per-Ola Freskgårds berufliches Profil anzeigen LinkedIn ist das weltweit größte berufliche Netzwerk, das Fach- und Führungskräften wie Per-Ola Freskgård dabei hilft, interne Kontakte zu finden, die mit empfohlenen Kandidaten, Branchenexperten und potenziellen Geschäftspartnern verbunden sind.

5 Hobbys & Interessen

(2017) Matrix metalloproteinase 9 is decreased in natalizumab-treated multiple sclerosis patients at risk for progressive multifocal leukoencephalopathy. Annals of Neurology Per-Ola Freskgård, Eduard Urich. . (2017) Antibody therapies in CNS diseases. Neuropharmacology 120,

E. D. Hood, J. Elliott, M. Gonzalez, K. Muffly, J. Strom, M. VanAuker. Published For a 1-hour incubation of immunoniosomes at a concentration of 3.0 × 107#/ mL and a cell density of × 105 cells/cm2, binding density was ± per cell. Conclusions We Per-Ola Freskgård et al., Medscape.

1 Business-Profile

Per-Ola Freskgård of Roche, Basel with expertise in Neuroscience, Biotechnology, Structural Biology is on ResearchGate M Osterlund. Egon Persson. Uno Carlsson; [...] Magdalena Svensson. Vessel wall tissue factor (TF) is exposed to blood upon vascular damage which enables association with factor VIIa (FVIIa).

1 Infos zur Ausbildung

... Wei Pan, Michael Prummer, Curtis Warren, Oliver Wernet, Roland Jakob-Roetne, Ulrich Certa, Ravi Jagasia, Per-Ola Freskgård, Isaac Adatto, Dorothee Kling, Paul Huang, Leonard I Zon, Elliot Chaikof, Robert E. Gerzsten, Martin Graf, Roberto Iacone and Chad A. Cowan. Nature Cell Biology Aug;17(8):

3 Bücher zum Namen

Juergen M. Schanzer, Katharina Wartha, Ekkehard Moessner, Ralf J. Hosse, Samuel Moser, Rebecca Croasdale, Halina Trochanowska, Cuiying Shao, Peng Wang, Lei Shi, Tina Weinzierl, Natascha Hadassah Sade, Claudia Baumgartner, Adrian Hugenmatter, Ekkehard Moessner, Per-Ola Freskgård, Jens Niewoehner.

Per-Ola Freskgård et al., Medscape. Fundamentals of X-ray Crystallography, second edition. By Dongcai Liang. Beijing: Science Press/Oxford: Alpha Science International Ltd, Pp. xi + Price GBP ISBN Nespolo et al., Acta Crystallographica Section A. Powered by TrendMD ...

8 Dokumente

Per-Ola Freskgård,*,‡ Lars C. Petersen,‡ Don A. Gabriel,§ Xiao Li,§ and Egon Persson*,‡. Vessel Wall Biology, Health Care DiscoVery, NoVo Nordisk A/S, Niels Steensens Vej 1, DK Gentofte, Denmark, and. Center for Thrombosis and Hemostasis and DiVision of Hematology/Oncology, UniVersity of North Carolina ...

the underlying methodological theories. Finally, I summarize the papers this thesis is based upon, which are also included in the last section of this thesis. I have carried out my research at Linköping University and it has been performed in cooperation with Egon Persson and Per-Ola Freskgård with coworkers at Novo.

Synapsin I phosphorylated by Ca, calmodulin‐dependent protein kinase II is able to self‐degrade. Authors: A.N. Gubin, S.E Authors: Per-Ola Freskgård, Uno Carlsson, Lars-Göran Mårtensson, Bengt-Harald Jonsson; First Published: 2 September 1991; Vol: 289,; Pages: 117–122; DOI: (91) P.

Rudy Chang , Jillian Knox , Jae Chang , Aram Derbedrossian , Vitaly Vasilevko , David Cribbs , Ruben J. Boado , William M. Pardridge , and Rachita K. Sumbria Sade , Peter Maier , Petra Rueger , Jan Olaf Stracke , Wilma Lau , Alain C. Tissot , Hansruedi Loetscher , Anirvan Ghosh , Per-Ola Freskgård.

4 Wissenschaftliche Publikationen

LARS C. PETERSEN,1 OLE H. OLSEN,2 LARS S. NIELSEN,3 PER-OLA FRESKGÅRD,1. AND EGON PERSSON1. 1Tissue two Zn2+ are bidentately bridged by Glu215$75%. Other ligands to Zn1 are the carboxylates. Table 1. Effect of Zn2+ on the binding of factor VIIa to tissue factor. @Zn2+#. ~mM! kon a. ~105 M. J1.

Per-Ola Freskgård, Nils Bergenhem, Bengt-Harald Jonsson, Magdalena Svensson and Uno Carlsson. Stable URL: http://www.jstor.org/stable Jeanette M. Rutz, Jun Liu, Jeri Ann Lyons, Joanne Goranson, Sandra K. Armstrong, Mark A. McIntosh, Jimmy B. Feix and Phillip E. Klebba. Stable URL: http://www.jstor.org /stable/ ...

More Support for Gut-Brain Link in Autism. Megan Brooks et al., Medscape. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape. Dysbiosis and zonulin upregulation alter gut epithelial and vascular barriers in patients with ankylosing spondylitis. Heleen Cypers et al., Ann Rheum Dis.

3 Meinungen & Artikel

The Roche study was co-led by Per-Ola Freskgård of the company's Neuroscience Discovery and Translation Area in Basel and Anirvan Ghosh of Roche's Rauchenberger R, Richter WF, Rothe C, Urban M, Bardroff M, Winter M, Nordstedt C, Loetscher H. Gantenerumab: A Novel Human Anti-Aβ Antibody ...

The Roche study was co-led by Per-Ola Freskgård of the company's Neuroscience Discovery and Translation Area in Basel and Anirvan Ghosh of Roche's Large Molecule Research unit in Penzberg, Germany. The Brain Shuttle takes advantage of TfR-mediated transcytosis, a well-known path across the ...

54 Webfunde aus dem Netz

Inventors, Henrik Pedersen, Alex Haahr Gouilaev, Christian Klarner Sams, Frank Abilgaard Sløk, Per-Ola Freskgård, Anette Holtmann, Olsen Eva Kampmann, Gitte Nystrup Husemoen, Jakob Felding, Thomas Franch, Thomas Thisted, Lene Hyldtoft, Mads Nørregaard-Madsen, Michael Anders Godskesen, GLAD Sanne ...

Izumitelji, Henrik Pedersen, Alex Haahr Gouliaev, Christian Klarner Sams, Frank Abilgaard Sløk, Per-Ola Freskgård, Anette Holtmann, Eva Kampmann Olsen, Gitte Nystrup Husemoen, Jakob Felding, Thomas Franch, Thomas Thisted, Lene Hyldtoft, Mads Nørregaard-Madsen, Michael Anders Godskesen, Sanne Schrøder ...

... Birgitte Nystrup Husemoen, Johannes Dolberg, Lene Petersen, Mads Nørregaard-Madsen, Michael Anders Godskesen, Sanne Schrøder GLAD, Søren NEVE, Thomas Thisted, Tine Titilola Akinleminu Kronberg, Christian Sams, Jakob Felding, Per-Ola Freskgård, Alex Haahr Gouliaev, Henrik Pedersen, ...

Dick Andersson, Uno Carlsson and Per-Ola Freskgård · Contribution of tryptophan residues to the CD spectrum of the extracellular domain of human tissue factor: Application in folding studies and prediction of secondary structure. European Journal of Biochemistry, 2001, 268(4), Web of Science® Times Cited: ...

Per-Ola Freskgård et al., Medscape. IP Update: Boston University, Korea Basic Science Institute among Recent Bioinformatics Patent Winners. GenomeWeb. New Findings Related to Childhood-Onset Psychopathology. Manpreet K. Singh et al., CancerNetwork. Crowdsourcing Combined with Experimental Testing Results ...

Per-Ola Freskgård et al., Medscape. Orthopaedic traumatology: fundamental principles and current controversies for the acute care surgeon. Shad K Pharaon et al., TSACO. Biological imaging using light-addressable potentiometric sensors and scanning photo-induced impedance microscopy. Fan Wu et ...

Shujing Liu et al., Medscape. Transcriptomic analysis of juvenile wood formation during the growing season in Pinus canariensis. Víctor Chano et al., Holzforschung. The Biology of Memory and Learning. Sara M. Mariani, MD, PhD, Medscape. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al.

Lars C. Petersen,* Per-Ola Freskgård, and Mirella Ezban. Tissue factor (TF) is known primary as a cofactor for factor VIIa-mediated triggering of blood coagulation, which proceeds in a cascade of extracellu- lar reactions. Recent investigations have, however, revealed that intracel- lular activities can also be induced by the ...

Linda L Demer et al., Heart. The First Negative Allosteric Modulator for Dopamine D2 and D3 Receptors SB May Lead to a New Generation of Antipsychotic Drugs. Mario Rossi et al., Mol Pharmacol. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape.

P23 A three dimensional (3D) human in vitro blood-brain barrier (BBB). P Miranda Azpiazu et al., Heart Reduced pericyte insulin signalling causes abnormal developmental angiogenesis. Nele Warmke et al., Heart. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., ...

Antibodies to Protect Against and Treat HIV. MedPage Today. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape. Glucagon Receptor Blockade Lowers Blood Glucose in Animals. Salynn Boyles, MedPage Today. Powered by TrendMD ...

Eduard Urich , Stanley E. Lazic , Juliette Molnos , Isabelle Wells , Per-Ola Freskgård , Ken Arai. PLoS ONE. May 2012, Vol. 7, No. 5: e Dynamic monitoring of β-cell injury with impedance and rescue by glucagon-like peptide-1. Ni Guan , Weiwei Gao , Min He , Min Zheng , Xiao Xu , Xiaobo Wang , Ming-Wei Wang.

Hadassah Sade, Claudia Baumgartner, Adrian Hugenmatter, Ekkehard Moessner, Per-Ola Freskgård, Jens Niewoehner, Felix Schlachetzki. PLoS ONE Eleanor J. Cheadle, Lauren Sidon, Simon J. Dovedi, Monique H.M. Melis, Waleed Alduaij, Tim M. Illidge, Jamie Honeychurch. British Journal of ...

Per-Ola Freskgård et al., Medscape. MEDLINE Abstracts: Monoclonal Antibody-Based Therapies. Medscape. New Genome Functions Pile On. GenomeWeb. Mutations in EFL1, an SBDS partner, are associated with infantile pancytopenia, exocrine pancreatic insufficiency and skeletal anomalies in a Shwachman-Diamond ...

Per-Ola Freskgård et al., Medscape. Gpr124 is Essential for Blood–Brain Barrier Integrity in CNS Disease. PracticeUpdate. More Support for Gut-Brain Link in Autism. Megan Brooks et al., Medscape. Penetrating the Blood–Brain Barrier to Treat EGFR-Mutated NSCLC With CNS Metastases. PracticeUpdate.

Ali Hassanvand, M.Sc. , and Shahriar Gharibzadeh, M.D., Ph.D. Published online : January 01, | https://doi.org appi.neuropsych · Citation · Full Text · References ... Elaine Siegfried, Cancer Therapy Advisor. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape.

Ramachandran Vignesh, Esaki M. Shankar ... Giulia M. Stella, Silvia Benvenuti, Alessandra Gentile, Paolo M. Comoglio ... Hoernschemeyer, Christophe Schweitzer, Tina Bülau, Achim Gärtner, Eike Hoffmann, Jens Niewoehner, Christoph Patsch, Karlheinz Baumann, Hansruedi Loetscher, Eric Kitas, Per-Ola Freskgård.

... Stephanie J. Grainger, Friedrich G. Kapp, Lin Sun, Klaus Christensen, Yulei Xia, Mary H. C. Florido, Wei He, Wei Pan, Michael Prummer, Curtis R. Warren, Roland Jakob-Roetne, Ulrich Certa, Ravi Jagasia, Per-Ola Freskgård, Isaac Adatto, Dorothee Kling, Paul Huang, Leonard I. Zon, Elliot L. Chaikof, Robert E. Gerszten, ...

Mauro Ferrari et al., Medscape. Making drugs safer: improving drug delivery and reducing the side effect of drugs on the human biochemical system. Odiba, Arome et al., Nanotechnol Rev. Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape. Targeted Nanomedicines, Treatment for ...

Time to Open the Blood-Brain Barrier Gate for Biologics? Per-Ola Freskgård et al., Medscape. Immunosuppressive Therapies in Organ Transplantation. Medscape. More Positive Data on Aducanumab in Alzheimer's. Susan Jeffrey et al., Medscape. Powered by TrendMD.